Line 1: |
Line 1: |
| ==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== | | ==Myeloid proliferations and neoplasms ([[Myeloid proliferations and neoplasms|Overview Page Link]])== |
− | ===Myeloid precursor lesions===
| + | '''Myeloid precursor lesions''' |
| ''Clonal Haematopoiesis'' | | ''Clonal Haematopoiesis'' |
| - [[Clonal haematopoiesis]] | | - [[Clonal haematopoiesis]] |
| - [[Clonal cytopenias of undetermined significance]] | | - [[Clonal cytopenias of undetermined significance]] |
− | ===Myeloproliferative neoplasms===
| + | '''Myeloproliferative neoplasms''' |
| ''Myeloproliferative neoplasms'' | | ''Myeloproliferative neoplasms'' |
| - [[Chronic myeloid leukaemia]] | | - [[Chronic myeloid leukaemia]] |
Line 14: |
Line 14: |
| - [[Juvenile myelomonocytic leukaemia]] | | - [[Juvenile myelomonocytic leukaemia]] |
| - [[Myeloproliferative neoplasm, NOS]] | | - [[Myeloproliferative neoplasm, NOS]] |
− | ===Mastocytosis===
| + | '''Mastocytosis''' |
| - [[Cutaneous mastocytosis]] | | - [[Cutaneous mastocytosis]] |
| - [[Systemic mastocytosis]] | | - [[Systemic mastocytosis]] |
| - [[Mast cell sarcoma]] | | - [[Mast cell sarcoma]] |
− | ===Myelodysplastic neoplasms===
| + | '''Myelodysplastic neoplasms''' |
| ''Myelodysplastic neoplasms, with defining genetic abnormalities'' | | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' |
| - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] | | - [[Myelodysplastic neoplasm with low blasts and 5q deletion]] |
Line 30: |
Line 30: |
| - [[Childhood myelodysplastic neoplasm with low blasts]] | | - [[Childhood myelodysplastic neoplasm with low blasts]] |
| - [[Childhood myelodysplastic neoplasm with increased blasts]] | | - [[Childhood myelodysplastic neoplasm with increased blasts]] |
− | ===Myelodysplastic/myeloproliferative neoplasms===
| + | '''Myelodysplastic/myeloproliferative neoplasms''' |
| - [[Chronic myelomonocytic leukaemia]] | | - [[Chronic myelomonocytic leukaemia]] |
| - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | | - [[Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] |
| - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] | | - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] |
| - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | | - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] |
− | ===Acute myeloid leukaemia===
| + | '''Acute myeloid leukaemia''' |
| ''Acute myeloid leukaemia with defining genetic abnormalities'' | | ''Acute myeloid leukaemia with defining genetic abnormalities'' |
| - [[Acute promyelocytic leukaemia with PML::RARA fusion]] | | - [[Acute promyelocytic leukaemia with PML::RARA fusion]] |
Line 61: |
Line 61: |
| ''Myeloid sarcoma'' | | ''Myeloid sarcoma'' |
| - [[Myeloid sarcoma]] | | - [[Myeloid sarcoma]] |
− | ===Myeloid neoplasms, secondary===
| + | '''Myeloid neoplasms, secondary''' |
| ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' | | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' |
| - [[Myeloid neoplasm post cytotoxic therapy]] | | - [[Myeloid neoplasm post cytotoxic therapy]] |
| - [[Myeloid neoplasms associated with germline predisposition]] | | - [[Myeloid neoplasms associated with germline predisposition]] |
| - [[Myeloid proliferations associated with Down syndrome]] | | - [[Myeloid proliferations associated with Down syndrome]] |
− | ===Myeloid/lymphoid neoplasms===
| + | '''Myeloid/lymphoid neoplasms''' |
| ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' | | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' |
| - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] | | - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]] |
Line 75: |
Line 75: |
| - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | | - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] |
| - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | | - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] |
− | ===Acute leukaemias of mixed or ambiguous lineage===
| + | '''Acute leukaemias of mixed or ambiguous lineage''' |
| ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' | | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' |
| - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] | | - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]] |
Line 87: |
Line 87: |
| - [[Acute undifferentiated leukaemia]] | | - [[Acute undifferentiated leukaemia]] |
| ==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== | | ==Histiocytic/Dendritic cell neoplasms ([[Histiocytic/Dendritic cell neoplasms|Overview Page Link]])== |
− | ===Plasmacytoid dendritic cell neoplasms===
| + | '''Plasmacytoid dendritic cell neoplasms''' |
| ''Plasmacytoid dendritic cell neoplasms'' | | ''Plasmacytoid dendritic cell neoplasms'' |
| - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | | - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] |
| - [[Blastic plasmacytoid dendritic cell neoplasm]] | | - [[Blastic plasmacytoid dendritic cell neoplasm]] |
− | ===Langerhans cell and other dendritic cell neoplasms===
| + | '''Langerhans cell and other dendritic cell neoplasms''' |
| ''Langerhans cells neoplasms'' | | ''Langerhans cells neoplasms'' |
| - [[Langerhans cell histiocytosis]] | | - [[Langerhans cell histiocytosis]] |
Line 98: |
Line 98: |
| - [[Indeterminate dendritic cell tumour]] | | - [[Indeterminate dendritic cell tumour]] |
| - [[Interdigitating dendritic cell sarcoma]] | | - [[Interdigitating dendritic cell sarcoma]] |
− | ===Histiocyte/macrophage neoplasms===
| + | '''Histiocyte/macrophage neoplasms''' |
| ''Histiocytic neoplasms'' | | ''Histiocytic neoplasms'' |
| - [[Juvenile xanthogranuloma]] | | - [[Juvenile xanthogranuloma]] |
Line 106: |
Line 106: |
| - [[Histiocytic sarcoma]] | | - [[Histiocytic sarcoma]] |
| ==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== | | ==B-cell lymphoid proliferations and lymphomas ([[B-cell lymphoid proliferations and lymphomas|Overview Page Link]])== |
− | ===Tumour like lesions with B-cell predominance===
| + | '''Tumour like lesions with B-cell predominance''' |
| - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
| - [[IgG4-related disease]] | | - [[IgG4-related disease]] |
Line 112: |
Line 112: |
| - [[Idiopathic multicentric Castleman disease]] | | - [[Idiopathic multicentric Castleman disease]] |
| - [[KSHV/HHV8-associated multicentric Castleman disease]] | | - [[KSHV/HHV8-associated multicentric Castleman disease]] |
− | ===Precursor B-cell neoplasms===
| + | '''Precursor B-cell neoplasms''' |
| ''B-lymphoblastic leukaemias/lymphomas'' | | ''B-lymphoblastic leukaemias/lymphomas'' |
| - [[B-lymphoblastic leukaemia/lymphoma]] | | - [[B-lymphoblastic leukaemia/lymphoma]] |
Line 128: |
Line 128: |
| - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | | - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] |
| - [[B-lymphoblastic leukaemia/lymphoma, NOS]] | | - [[B-lymphoblastic leukaemia/lymphoma, NOS]] |
− | ===Mature B-cell neoplasms===
| + | '''Mature B-cell neoplasms''' |
| ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' | | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' |
| - [[Monoclonal B-cell lymphocytosis]] | | - [[Monoclonal B-cell lymphocytosis]] |
Line 188: |
Line 188: |
| - [[Lymphomas arising in immune deficiency / dysregulation ]] | | - [[Lymphomas arising in immune deficiency / dysregulation ]] |
| - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | | - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] |
− | ===Hodgkin lymphoma===
| + | '''Hodgkin lymphoma''' |
| - [[Classic Hodgkin lymphoma ]] | | - [[Classic Hodgkin lymphoma ]] |
| - [[Nodular lymphocyte predominant Hodgkin lymphoma]] | | - [[Nodular lymphocyte predominant Hodgkin lymphoma]] |
− | ===Plasma cell neoplasms and other diseases with paraproteins===
| + | '''Plasma cell neoplasms and other diseases with paraproteins''' |
| ''Monoclonal gammopathies'' | | ''Monoclonal gammopathies'' |
| - [[Cold agglutinin disease ]] | | - [[Cold agglutinin disease ]] |
Line 209: |
Line 209: |
| - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] | | - [[Plasma cell neoplasms with associated paraneoplastic syndrome]] |
| ==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== | | ==T-cell and NK-cell lymphoid proliferations and lymphomas ([[T-cell and NK-cell lymphoid proliferations and lymphomas |Overview Page Link]])== |
− | ===Tumour-like lesions with T-cell predominance===
| + | '''Tumour-like lesions with T-cell predominance''' |
| - [[Kikuchi-Fujimoto disease]] | | - [[Kikuchi-Fujimoto disease]] |
| - [[Autoimmune lymphoproliferative syndrome]] | | - [[Autoimmune lymphoproliferative syndrome]] |
| - [[Indolent T-lymphoblastic proliferation]] | | - [[Indolent T-lymphoblastic proliferation]] |
− | ===Precursor T-cell neoplasms===
| + | '''Precursor T-cell neoplasms''' |
| ''T-lymphoblastic leukaemia / lymphoma'' | | ''T-lymphoblastic leukaemia / lymphoma'' |
| - [[T-lymphoblastic leukaemia / lymphoma, NOS]] | | - [[T-lymphoblastic leukaemia / lymphoma, NOS]] |
| - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] | | - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] |
− | ===Mature T-cell and NK-cell neoplasms===
| + | '''Mature T-cell and NK-cell neoplasms''' |
| ''Mature T-cell and NK-cell leukaemias'' | | ''Mature T-cell and NK-cell leukaemias'' |
| - [[T-prolymphocytic leukaemia]] | | - [[T-prolymphocytic leukaemia]] |
Line 262: |
Line 262: |
| - [[Systemic EBV-positive T-cell lymphoma of childhood]] | | - [[Systemic EBV-positive T-cell lymphoma of childhood]] |
| ==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== | | ==Stroma-derived neoplasms of lymphoid tissues ([[Stroma-derived neoplasms of lymphoid tissues|Overview Page Link]])== |
− | ===Mesenchymal dendritic cell neoplasms===
| + | '''Mesenchymal dendritic cell neoplasms''' |
| ''Follicular dendritic cell neoplasms'' | | ''Follicular dendritic cell neoplasms'' |
| - [[Follicular dendritic cell sarcoma]] | | - [[Follicular dendritic cell sarcoma]] |
| - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] | | - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| - [[Fibroblastic reticular cell tumour]] | | - [[Fibroblastic reticular cell tumour]] |
− | ===Myofibroblastic tumours===
| + | '''Myofibroblastic tumours''' |
| ''Myofibroblastic tumour'' | | ''Myofibroblastic tumour'' |
| - [[Intranodal palisaded myofibroblastoma]] | | - [[Intranodal palisaded myofibroblastoma]] |
− | ===Spleen-specific vascular-stromal tumours===
| + | '''Spleen-specific vascular-stromal tumours''' |
| ''Splenic vascular-stromal tumours'' | | ''Splenic vascular-stromal tumours'' |
| - [[Littoral cell angioma]] | | - [[Littoral cell angioma]] |